PL2561880T3 - Bakterie kwasu mlekowego jako szczepy probiotyczne oraz kompozycje je zawierające - Google Patents
Bakterie kwasu mlekowego jako szczepy probiotyczne oraz kompozycje je zawierająceInfo
- Publication number
- PL2561880T3 PL2561880T3 PL12178634T PL12178634T PL2561880T3 PL 2561880 T3 PL2561880 T3 PL 2561880T3 PL 12178634 T PL12178634 T PL 12178634T PL 12178634 T PL12178634 T PL 12178634T PL 2561880 T3 PL2561880 T3 PL 2561880T3
- Authority
- PL
- Poland
- Prior art keywords
- lactic acid
- compositions containing
- acid bacteria
- containing same
- probiotic strains
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/23—Lactobacillus acidophilus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Physiology (AREA)
- Rheumatology (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2004011980 | 2004-10-22 | ||
| EP2004011981 | 2004-10-22 | ||
| EP2005001354 | 2005-02-10 | ||
| EP05795238A EP1812023B8 (en) | 2004-10-22 | 2005-10-17 | Lactic acid bacteria as probiotic strains and compositions containing same |
| EP12178634.7A EP2561880B1 (en) | 2004-10-22 | 2005-10-17 | Lactic acid bacteria as probiotic strains and compositions containing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2561880T3 true PL2561880T3 (pl) | 2015-02-27 |
Family
ID=35534903
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05795238T PL1812023T3 (pl) | 2004-10-22 | 2005-10-17 | Bakterie kwasu mlekowego jako szczepy probiotyczne i kompozycje je zawierające |
| PL12178634T PL2561880T3 (pl) | 2004-10-22 | 2005-10-17 | Bakterie kwasu mlekowego jako szczepy probiotyczne oraz kompozycje je zawierające |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05795238T PL1812023T3 (pl) | 2004-10-22 | 2005-10-17 | Bakterie kwasu mlekowego jako szczepy probiotyczne i kompozycje je zawierające |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US20100196340A1 (pl) |
| EP (3) | EP1802319A1 (pl) |
| JP (1) | JP2008517014A (pl) |
| DK (1) | DK2561880T3 (pl) |
| ES (2) | ES2392172T3 (pl) |
| PL (2) | PL1812023T3 (pl) |
| WO (3) | WO2006045347A1 (pl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006045474A1 (en) * | 2004-10-22 | 2006-05-04 | Medinova Ag | Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same |
| EP2206506A1 (en) * | 2008-12-18 | 2010-07-14 | Bracco Imaging S.p.A | Probiotic formulations |
| BG66608B1 (bg) * | 2011-05-04 | 2017-10-16 | "Ел Би Булгарикум" ЕАД | Полибактериален пробиотичен препарат |
| FR2992861B1 (fr) | 2012-07-09 | 2014-10-17 | Probionov | Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles |
| FR2992973B1 (fr) | 2012-07-09 | 2015-12-18 | S P M D | Nouvelle souche de lactobacillus crispatus |
| CN103911306B (zh) * | 2013-01-05 | 2016-08-24 | 欣力菲生物医药技术(天津)有限公司 | 加氏乳杆菌菌株及其用途 |
| CN103911309B (zh) * | 2013-01-05 | 2016-08-24 | 欣力菲生物医药技术(天津)有限公司 | 加氏乳杆菌菌株及其用途 |
| US12246043B2 (en) | 2013-12-20 | 2025-03-11 | Seed Health, Inc. | Topical application to treat acne vulgaris |
| EP3064072A1 (en) * | 2015-02-11 | 2016-09-07 | AB-Biotics S.A. | Probiotic lactobacillus strains for use in treating urinary tract infections |
| FR3048361B1 (fr) | 2016-03-01 | 2020-12-18 | Biose | Compositions pour le traitement des candidoses |
| EP3423093A4 (en) | 2016-03-04 | 2019-11-13 | The Regents of The University of California | MICROBIAL CONSORTIUM AND USES THEREOF |
| EP3512532A1 (en) | 2016-09-16 | 2019-07-24 | DuPont Nutrition Biosciences ApS | Bacteria |
| CN110267670B (zh) * | 2016-10-20 | 2023-08-15 | 表飞鸣制药株式会社 | 对肠道的离子跨细胞转运体的作用剂、氯离子通道活化剂、肾脏疾病的预防或治疗剂或者排便促进剂 |
| CN110799198A (zh) * | 2016-11-30 | 2020-02-14 | 普罗生物瑞士股份公司 | 用于稳定阴道液的酸度和氧化还原状态的基于合适的生化组合物的泌尿生殖器医疗设备制剂 |
| EP3427745A1 (en) | 2017-07-12 | 2019-01-16 | Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO | New probiotic composition for prevention of bacterial vaginosis |
| CN113038957A (zh) | 2018-04-10 | 2021-06-25 | 谢尔塔治疗公司 | 微生物群 |
| JP7624449B2 (ja) | 2019-10-07 | 2025-01-30 | シオルタ・セラピューティクス,インコーポレイテッド | 治療用医薬組成物 |
| US11850303B2 (en) * | 2020-10-27 | 2023-12-26 | Uqora, Inc. | Gel and a suppository and methods to provide the gel and suppository |
| KR102337951B1 (ko) * | 2021-06-25 | 2021-12-13 | 주식회사 비피도 | 요로감염 개선, 예방 또는 치료를 위한 락토바실러스 헬베티쿠스 gut10 균주 및 이를 포함하는 조성물 |
| CN114717169B (zh) * | 2022-06-10 | 2022-08-23 | 南京益瑞兰生物科技有限公司 | 一种瑞士乳杆菌及其在制备调节生殖道微生态和缓解生殖道干涩产品中的应用 |
| WO2025104501A1 (en) | 2023-11-15 | 2025-05-22 | Freya Biosciences Aps | Microbial consortia and uses thereof |
| WO2025104499A1 (en) | 2023-11-15 | 2025-05-22 | Freya Biosciences Aps | Microbial consortia for treating vaginal conditions |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1234567A (en) * | 1915-09-14 | 1917-07-24 | Edward J Quigley | Soft collar. |
| DK242083D0 (da) * | 1983-05-27 | 1983-05-27 | Hansens Chr Bio Syst | Vaginalkapsler |
| IT1227154B (it) * | 1988-08-05 | 1991-03-19 | A Tosi Farmaceutici S R L Nova | Composizioni farmaceutiche per uso ginecologico a base di lattobacilli |
| SE8900546D0 (sv) * | 1989-02-17 | 1989-02-17 | Bioinvent Int Ab | Medel foer inhibering av patogeners adhesion tillvaext och /eller oeverlevnad |
| GB2261372A (en) * | 1991-11-15 | 1993-05-19 | Gregor Reid | Lactobacillus and skim milk compositions for prevention of urogenital infection |
| US6093394A (en) * | 1997-04-11 | 2000-07-25 | Gynelogix, Inc. | Vaginal lactobacillus medicant |
| DE69802260T2 (de) * | 1998-04-30 | 2002-07-04 | Renata Maria Anna Cavaliere Vesely | Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen |
| AU4059999A (en) * | 1998-06-05 | 1999-12-30 | Wakamoto Pharmaceutical Co., Ltd. | Lactic acid bacterium-containing compositions, drugs and foods |
| ATE290391T1 (de) * | 1998-12-11 | 2005-03-15 | Urex Biotech Inc | Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen |
| CA2374937A1 (en) * | 1999-05-25 | 2000-11-30 | Gregor Reid | Oral administration of lactobacillus for the maintenance of health in women |
| SE521022C2 (sv) * | 2001-09-20 | 2003-09-23 | Ellen Ab | Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa |
| JP2002193817A (ja) * | 2000-12-28 | 2002-07-10 | Calpis Co Ltd | 整腸剤 |
| PL212647B1 (pl) * | 2002-03-21 | 2012-11-30 | Bifodan As | Kompozycja farmaceutyczna, szczep Lactobacillus paracasei Lbp PB01 oraz szczep Lactobacillus paracasei Lbp PB01 w polaczeniu ze szczepem Lactobacillus acidophilus Lba EB01, produkt chlonny zawierajacy te kompozycje oraz produkt nabialowy, produkt nutraceutyczny i czynnosciowy produkt zywnosciowy zawierajace ten szczep albo te dwa szczepy, a takze zastosowanie tego szczepu albo tych dwóch szczepów |
| US7829079B2 (en) * | 2002-03-28 | 2010-11-09 | Christian Hansen A/S | Lactobacillus iners for the enhancement of urogenital health |
| US20040071679A1 (en) * | 2002-10-15 | 2004-04-15 | Claudio De Simone | Identifying and treating vaginal infections |
| WO2006045474A1 (en) * | 2004-10-22 | 2006-05-04 | Medinova Ag | Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same |
-
2005
- 2005-02-22 WO PCT/EP2005/001846 patent/WO2006045347A1/en not_active Ceased
- 2005-10-17 US US11/577,680 patent/US20100196340A1/en not_active Abandoned
- 2005-10-17 DK DK12178634.7T patent/DK2561880T3/da active
- 2005-10-17 WO PCT/EP2005/011150 patent/WO2006045473A1/en not_active Ceased
- 2005-10-17 EP EP05795969A patent/EP1802319A1/en not_active Withdrawn
- 2005-10-17 EP EP05795238A patent/EP1812023B8/en not_active Expired - Lifetime
- 2005-10-17 ES ES05795238T patent/ES2392172T3/es not_active Expired - Lifetime
- 2005-10-17 ES ES12178634.7T patent/ES2524432T3/es not_active Expired - Lifetime
- 2005-10-17 JP JP2007537179A patent/JP2008517014A/ja active Pending
- 2005-10-17 WO PCT/EP2005/011152 patent/WO2006045475A1/en not_active Ceased
- 2005-10-17 PL PL05795238T patent/PL1812023T3/pl unknown
- 2005-10-17 EP EP12178634.7A patent/EP2561880B1/en not_active Expired - Lifetime
- 2005-10-17 PL PL12178634T patent/PL2561880T3/pl unknown
-
2007
- 2007-04-20 US US11/738,102 patent/US20080019954A1/en not_active Abandoned
-
2016
- 2016-10-12 US US15/291,880 patent/US10213466B2/en not_active Expired - Lifetime
-
2019
- 2019-01-14 US US16/247,453 patent/US11040076B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP2561880A3 (en) | 2013-06-19 |
| PL1812023T3 (pl) | 2013-03-29 |
| EP2561880B1 (en) | 2014-08-27 |
| US10213466B2 (en) | 2019-02-26 |
| EP1812023B8 (en) | 2012-12-26 |
| ES2524432T3 (es) | 2014-12-09 |
| US20100196340A1 (en) | 2010-08-05 |
| US20080019954A1 (en) | 2008-01-24 |
| US11040076B2 (en) | 2021-06-22 |
| ES2392172T3 (es) | 2012-12-05 |
| WO2006045473A1 (en) | 2006-05-04 |
| US20190142878A1 (en) | 2019-05-16 |
| US20170027998A1 (en) | 2017-02-02 |
| WO2006045475A1 (en) | 2006-05-04 |
| EP2561880A2 (en) | 2013-02-27 |
| DK2561880T3 (da) | 2014-10-27 |
| JP2008517014A (ja) | 2008-05-22 |
| EP1812023B1 (en) | 2012-08-01 |
| EP1802319A1 (en) | 2007-07-04 |
| EP1812023A1 (en) | 2007-08-01 |
| WO2006045347A1 (en) | 2006-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1812023T3 (pl) | Bakterie kwasu mlekowego jako szczepy probiotyczne i kompozycje je zawierające | |
| PL2548455T3 (pl) | Kompozycja zawierająca bakterię kwasu mlekowego wytwarzającą ekwol | |
| IL173692A0 (en) | Bacterial strains, compositions including same and probiotic use thereof | |
| IL178686A (en) | Preparations of bacterial strain of lactic acid and their uses | |
| PL1931363T3 (pl) | Leczenie IBD z zastosowaniem zarówno bakterii probiotycznych, jak i sfermentowanych zbóż jako efektorów leczenia | |
| IL184555A0 (en) | Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough | |
| EP1941892A3 (en) | Anti-allergy lactic acid bacteria | |
| PL1673100T3 (pl) | Szczepy bakterii Bifidobacterium wytwarzające kwas foliowy, preparaty i ich zastosowanie | |
| PL1824500T3 (pl) | Probiotyczne szczepy Lactobacillus dla polepszenia stanu zdrowia pochwy | |
| IL202386A0 (en) | Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis | |
| ZA200908722B (en) | Freeze-dried,aerated dairy or diary-substitute compositions and methods of making thereof | |
| IL200407A (en) | Stable digestive enzyme preparations, methods of preparation and use thereof | |
| EP1661983A4 (en) | LACTIC FERMENT CAPABLE OF IMMUNOPOTENTIALIZATION OF MUCOUS MEMBRANES | |
| IL189610A0 (en) | Compositions and methods for producing apolipoprotein gene products in lactic acid bacteria | |
| AP2010005111A0 (en) | Composition comprising bacteria and lecithin | |
| WO2009065905A3 (en) | Composition with synbiotics | |
| IL206110A0 (en) | Composition for human and/or animal nutrition, uses thereof and yeasts | |
| EP1988155A4 (en) | LACTIC ACID BACTERIUM CAPABLE OF PRODUCING AMINO-ACUTE ACID | |
| EP2042590A4 (en) | AMPLIFIERS OF MILKIC ACID BACTERIA PREPARATION AND MEANS TO IMPROVE THE SURVIVAL OF MILKY ACID BACTERIA | |
| PL1901612T3 (pl) | Fermentowane produkty spożywcze zawierające szczepy probiotyczne i sposób ich wytwarzania | |
| AU2003255142A1 (en) | Composition containing ground lotus and/or lotus extract and lactic acid bacterium | |
| EP1848798A4 (en) | NEW MICROBIAL ENZYMES AND THEIR USE | |
| PL1891436T3 (pl) | Ilościowe określanie żywotności bakterii kwasu mlekowego z zastosowaniem cytometrii przepływowej | |
| PL1986502T3 (pl) | Składniki aromatyzujące i metoda aromatyzacji produktów mlecznych, szczep bakterii mlekowych, zastosowanie powyższych składników, metody lub szczepu | |
| AP2007004168A0 (en) | Bacteriocins and novel bacterial strains |